Artigo Revisado por pares

Adverse Reactions to the Intravesical Administration of Doxorubicin Hydrochloride: Report of 6 Cases

1986; Lippincott Williams & Wilkins; Volume: 136; Issue: 3 Linguagem: Inglês

10.1016/s0022-5347(17)45010-5

ISSN

1527-3792

Autores

E. David Crawford, David R. McKenzie, Wiking Månsson, Mattie Totonchy, H. Barton Grossman, M. Davis, Donald L. Lamm, M. Duchek,

Tópico(s)

Urological Disorders and Treatments

Resumo

No AccessJournal of Urology1 Sep 1986Adverse Reactions to the Intravesical Administration of Doxorubicin Hydrochloride: Report of 6 Cases E. David Crawford, David McKenzie, Wiking Mansson, Mattie Totonchy, H. Barton Grossman, Marilyn Davis, Donald L. Lamm, and Milos Duchek E. David CrawfordE. David Crawford Current address: Division of Urology, University of Colorado Health Sciences Center, Denver, Colorado 80220. More articles by this author , David McKenzieDavid McKenzie More articles by this author , Wiking ManssonWiking Mansson More articles by this author , Mattie TotonchyMattie Totonchy More articles by this author , H. Barton GrossmanH. Barton Grossman More articles by this author , Marilyn DavisMarilyn Davis More articles by this author , Donald L. LammDonald L. Lamm More articles by this author , and Milos DuchekMilos Duchek More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(17)45010-5AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail We report 6 cases of adverse systemic reactions to the intravesical instillation of doxorubicin hydrochloride for the treatment of recurrent superficial transitional cell carcinoma of the bladder. Although local reactions to this drug are common they rarely are life-threatening. Significant systemic toxicity has not been reported. © 1986 by The American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited ByAli-El-Dein B, El-Baz M, Aly A, Shamaa S and Ashamallah A (2018) Intravesical Epirubicin Versus Doxorubicin for Superficial Bladder Tumors (Stages pTa and pT1): a Randomized Prospective StudyJournal of Urology, VOL. 158, NO. 1, (68-74), Online publication date: 1-Jul-1997.Lee M and Sharifi R (2018) Generalized Hypersensitivity Reaction to Intravesical Thiotepa and DoxorubicinJournal of Urology, VOL. 138, NO. 1, (143-144), Online publication date: 1-Jul-1987. Volume 136Issue 3September 1986Page: 668-669 Advertisement Copyright & Permissions© 1986 by The American Urological Association Education and Research, Inc.MetricsAuthor Information E. David Crawford Current address: Division of Urology, University of Colorado Health Sciences Center, Denver, Colorado 80220. More articles by this author David McKenzie More articles by this author Wiking Mansson More articles by this author Mattie Totonchy More articles by this author H. Barton Grossman More articles by this author Marilyn Davis More articles by this author Donald L. Lamm More articles by this author Milos Duchek More articles by this author Expand All Advertisement PDF DownloadLoading ...

Referência(s)
Altmetric
PlumX